General Information of Drug Off-Target (DOT) (ID: OT6J9LJR)

DOT Name Laminin subunit beta-1 (LAMB1)
Synonyms Laminin B1 chain; Laminin-1 subunit beta; Laminin-10 subunit beta; Laminin-12 subunit beta; Laminin-2 subunit beta; Laminin-6 subunit beta; Laminin-8 subunit beta
Gene Name LAMB1
Related Disease
Neoplasm ( )
Adenocarcinoma ( )
Advanced cancer ( )
Autism ( )
Brain neoplasm ( )
Campomelic dysplasia ( )
Carcinoma ( )
Cobblestone lissencephaly without muscular or ocular involvement ( )
Coloboma ( )
Craniometaphyseal dysplasia, autosomal dominant ( )
Crohn disease ( )
Endometriosis ( )
Epilepsy ( )
Glioma ( )
Hepatocellular carcinoma ( )
Leiomyoma ( )
Pneumoconiosis ( )
Prostate neoplasm ( )
Ulcerative colitis ( )
Uterine fibroids ( )
Autism spectrum disorder ( )
Autoimmune disease ( )
Craniosynostosis ( )
Neurodevelopmental disorder ( )
Pervasive developmental disorder ( )
Pulmonary fibrosis ( )
Recessive X-linked ichthyosis ( )
Bethlem myopathy ( )
Colon adenocarcinoma ( )
Colorectal carcinoma ( )
Prostate cancer ( )
Prostate carcinoma ( )
UniProt ID
LAMB1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5XAU; 7CEC; 8DMK
Pfam ID
PF00053 ; PF21199 ; PF00055
Sequence
MGLLQLLAFSFLALCRARVRAQEPEFSYGCAEGSCYPATGDLLIGRAQKLSVTSTCGLHK
PEPYCIVSHLQEDKKCFICNSQDPYHETLNPDSHLIENVVTTFAPNRLKIWWQSENGVEN
VTIQLDLEAEFHFTHLIMTFKTFRPAAMLIERSSDFGKTWGVYRYFAYDCEASFPGISTG
PMKKVDDIICDSRYSDIEPSTEGEVIFRALDPAFKIEDPYSPRIQNLLKITNLRIKFVKL
HTLGDNLLDSRMEIREKYYYAVYDMVVRGNCFCYGHASECAPVDGFNEEVEGMVHGHCMC
RHNTKGLNCELCMDFYHDLPWRPAEGRNSNACKKCNCNEHSISCHFDMAVYLATGNVSGG
VCDDCQHNTMGRNCEQCKPFYYQHPERDIRDPNFCERCTCDPAGSQNEGICDSYTDFSTG
LIAGQCRCKLNVEGEHCDVCKEGFYDLSSEDPFGCKSCACNPLGTIPGGNPCDSETGHCY
CKRLVTGQHCDQCLPEHWGLSNDLDGCRPCDCDLGGALNNSCFAESGQCSCRPHMIGRQC
NEVEPGYYFATLDHYLYEAEEANLGPGVSIVERQYIQDRIPSWTGAGFVRVPEGAYLEFF
IDNIPYSMEYDILIRYEPQLPDHWEKAVITVQRPGRIPTSSRCGNTIPDDDNQVVSLSPG
SRYVVLPRPVCFEKGTNYTVRLELPQYTSSDSDVESPYTLIDSLVLMPYCKSLDIFTVGG
SGDGVVTNSAWETFQRYRCLENSRSVVKTPMTDVCRNIIFSISALLHQTGLACECDPQGS
LSSVCDPNGGQCQCRPNVVGRTCNRCAPGTFGFGPSGCKPCECHLQGSVNAFCNPVTGQC
HCFQGVYARQCDRCLPGHWGFPSCQPCQCNGHADDCDPVTGECLNCQDYTMGHNCERCLA
GYYGDPIIGSGDHCRPCPCPDGPDSGRQFARSCYQDPVTLQLACVCDPGYIGSRCDDCAS
GYFGNPSEVGGSCQPCQCHNNIDTTDPEACDKETGRCLKCLYHTEGEHCQFCRFGYYGDA
LQQDCRKCVCNYLGTVQEHCNGSDCQCDKATGQCLCLPNVIGQNCDRCAPNTWQLASGTG
CDPCNCNAAHSFGPSCNEFTGQCQCMPGFGGRTCSECQELFWGDPDVECRACDCDPRGIE
TPQCDQSTGQCVCVEGVEGPRCDKCTRGYSGVFPDCTPCHQCFALWDVIIAELTNRTHRF
LEKAKALKISGVIGPYRETVDSVERKVSEIKDILAQSPAAEPLKNIGNLFEEAEKLIKDV
TEMMAQVEVKLSDTTSQSNSTAKELDSLQTEAESLDNTVKELAEQLEFIKNSDIRGALDS
ITKYFQMSLEAEERVNASTTEPNSTVEQSALMRDRVEDVMMERESQFKEKQEEQARLLDE
LAGKLQSLDLSAAAEMTCGTPPGASCSETECGGPNCRTDEGERKCGGPGCGGLVTVAHNA
WQKAMDLDQDVLSALAEVEQLSKMVSEAKLRADEAKQSAEDILLKTNATKEKMDKSNEEL
RNLIKQIRNFLTQDSADLDSIEAVANEVLKMEMPSTPQQLQNLTEDIRERVESLSQVEVI
LQHSAADIARAEMLLEEAKRASKSATDVKVTADMVKEALEEAEKAQVAAEKAIKQADEDI
QGTQNLLTSIESETAASEETLFNASQRISELERNVEELKRKAAQNSGEAEYIEKVVYTVK
QSAEDVKKTLDGELDEKYKKVENLIAKKTEESADARRKAEMLQNEAKTLLAQANSKLQLL
KDLERKYEDNQRYLEDKAQELARLEGEVRSLLKDISQKVAVYSTCL
Function
Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Involved in the organization of the laminar architecture of cerebral cortex. It is probably required for the integrity of the basement membrane/glia limitans that serves as an anchor point for the endfeet of radial glial cells and as a physical barrier to migrating neurons. Radial glial cells play a central role in cerebral cortical development, where they act both as the proliferative unit of the cerebral cortex and a scaffold for neurons migrating toward the pial surface.
KEGG Pathway
PI3K-Akt sig.ling pathway (hsa04151 )
Focal adhesion (hsa04510 )
ECM-receptor interaction (hsa04512 )
Toxoplasmosis (hsa05145 )
Amoebiasis (hsa05146 )
Human papillomavirus infection (hsa05165 )
Pathways in cancer (hsa05200 )
Small cell lung cancer (hsa05222 )
Reactome Pathway
Laminin interactions (R-HSA-3000157 )
Non-integrin membrane-ECM interactions (R-HSA-3000171 )
ECM proteoglycans (R-HSA-3000178 )
L1CAM interactions (R-HSA-373760 )
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) (R-HSA-381426 )
MET activates PTK2 signaling (R-HSA-8874081 )
Post-translational protein phosphorylation (R-HSA-8957275 )
EGR2 and SOX10-mediated initiation of Schwann cell myelination (R-HSA-9619665 )
Degradation of the extracellular matrix (R-HSA-1474228 )

Molecular Interaction Atlas (MIA) of This DOT

32 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Biomarker [1]
Adenocarcinoma DIS3IHTY Strong Biomarker [2]
Advanced cancer DISAT1Z9 Strong Biomarker [3]
Autism DISV4V1Z Strong Genetic Variation [4]
Brain neoplasm DISY3EKS Strong Biomarker [5]
Campomelic dysplasia DISVTW53 Strong Altered Expression [6]
Carcinoma DISH9F1N Strong Altered Expression [2]
Cobblestone lissencephaly without muscular or ocular involvement DIS74G5S Strong Autosomal recessive [7]
Coloboma DISP39N5 Strong Biomarker [8]
Craniometaphyseal dysplasia, autosomal dominant DISU12OO Strong Altered Expression [6]
Crohn disease DIS2C5Q8 Strong Biomarker [9]
Endometriosis DISX1AG8 Strong Biomarker [10]
Epilepsy DISBB28L Strong Altered Expression [11]
Glioma DIS5RPEH Strong Altered Expression [12]
Hepatocellular carcinoma DIS0J828 Strong Altered Expression [13]
Leiomyoma DISLDDFN Strong Altered Expression [14]
Pneumoconiosis DISSJLBN Strong Genetic Variation [15]
Prostate neoplasm DISHDKGQ Strong Altered Expression [16]
Ulcerative colitis DIS8K27O Strong Biomarker [9]
Uterine fibroids DISBZRMJ Strong Altered Expression [14]
Autism spectrum disorder DISXK8NV moderate Genetic Variation [4]
Autoimmune disease DISORMTM moderate Biomarker [17]
Craniosynostosis DIS6J405 moderate Genetic Variation [18]
Neurodevelopmental disorder DIS372XH moderate Altered Expression [4]
Pervasive developmental disorder DIS51975 moderate Genetic Variation [4]
Pulmonary fibrosis DISQKVLA moderate Altered Expression [15]
Recessive X-linked ichthyosis DISZY56W moderate Biomarker [19]
Bethlem myopathy DISVF5K2 Limited Altered Expression [20]
Colon adenocarcinoma DISDRE0J Limited Biomarker [21]
Colorectal carcinoma DIS5PYL0 Limited Biomarker [21]
Prostate cancer DISF190Y Limited Biomarker [1]
Prostate carcinoma DISMJPLE Limited Genetic Variation [22]
------------------------------------------------------------------------------------
⏷ Show the Full List of 32 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Mitoxantrone DMM39BF Approved Laminin subunit beta-1 (LAMB1) affects the response to substance of Mitoxantrone. [48]
------------------------------------------------------------------------------------
26 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Laminin subunit beta-1 (LAMB1). [23]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Laminin subunit beta-1 (LAMB1). [24]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Laminin subunit beta-1 (LAMB1). [25]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Laminin subunit beta-1 (LAMB1). [26]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Laminin subunit beta-1 (LAMB1). [27]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Laminin subunit beta-1 (LAMB1). [28]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Laminin subunit beta-1 (LAMB1). [29]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Laminin subunit beta-1 (LAMB1). [31]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Laminin subunit beta-1 (LAMB1). [32]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Laminin subunit beta-1 (LAMB1). [33]
Zoledronate DMIXC7G Approved Zoledronate decreases the expression of Laminin subunit beta-1 (LAMB1). [34]
Phenobarbital DMXZOCG Approved Phenobarbital affects the expression of Laminin subunit beta-1 (LAMB1). [35]
Nicotine DMWX5CO Approved Nicotine increases the expression of Laminin subunit beta-1 (LAMB1). [36]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate decreases the expression of Laminin subunit beta-1 (LAMB1). [37]
Dasatinib DMJV2EK Approved Dasatinib increases the expression of Laminin subunit beta-1 (LAMB1). [38]
Cocaine DMSOX7I Approved Cocaine increases the expression of Laminin subunit beta-1 (LAMB1). [39]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Laminin subunit beta-1 (LAMB1). [40]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Laminin subunit beta-1 (LAMB1). [41]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Laminin subunit beta-1 (LAMB1). [42]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 increases the expression of Laminin subunit beta-1 (LAMB1). [43]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN increases the expression of Laminin subunit beta-1 (LAMB1). [44]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Laminin subunit beta-1 (LAMB1). [45]
chloropicrin DMSGBQA Investigative chloropicrin decreases the expression of Laminin subunit beta-1 (LAMB1). [46]
3R14S-OCHRATOXIN A DM2KEW6 Investigative 3R14S-OCHRATOXIN A decreases the expression of Laminin subunit beta-1 (LAMB1). [40]
Bilirubin DMI0V4O Investigative Bilirubin decreases the expression of Laminin subunit beta-1 (LAMB1). [47]
Methyl Mercury Ion DM6YEW4 Investigative Methyl Mercury Ion decreases the expression of Laminin subunit beta-1 (LAMB1). [40]
------------------------------------------------------------------------------------
⏷ Show the Full List of 26 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Laminin subunit beta-1 (LAMB1). [30]
------------------------------------------------------------------------------------

References

1 Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.Cancer Res. 2015 Jul 15;75(14):2949-60. doi: 10.1158/0008-5472.CAN-14-3297. Epub 2015 May 27.
2 Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas.Am J Pathol. 1993 May;142(5):1622-30.
3 Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement.Am J Surg Pathol. 1996;20 Suppl 1:S8-22. doi: 10.1097/00000478-199600001-00003.
4 LAMB1 polymorphism is associated with autism symptom severity in Korean autism spectrum disorder patients.Nord J Psychiatry. 2015;69(8):594-8. doi: 10.3109/08039488.2015.1022597. Epub 2015 Mar 16.
5 Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.Front Biosci. 2006 Jan 1;11:81-8. doi: 10.2741/1781.
6 Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.Neuropediatrics. 1997 Aug;28(4):217-22. doi: 10.1055/s-2007-973703.
7 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
8 Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease.Hum Mol Genet. 2008 Dec 15;17(24):3987-4000. doi: 10.1093/hmg/ddn302. Epub 2008 Sep 22.
9 Genetic determinants associated with early age of diagnosis of IBD.Dis Colon Rectum. 2015 Mar;58(3):321-7. doi: 10.1097/DCR.0000000000000274.
10 Molecular evidence for differences in endometrium in severe versus mild endometriosis.Reprod Sci. 2011 Mar;18(3):229-51. doi: 10.1177/1933719110386241. Epub 2010 Nov 9.
11 Expression of laminin beta1 in hippocampi of patients with intractable epilepsy.Neurosci Lett. 2008 Oct 10;443(3):160-4. doi: 10.1016/j.neulet.2008.07.080. Epub 2008 Aug 5.
12 MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.Neuro Oncol. 2014 May;16(5):637-51. doi: 10.1093/neuonc/not300. Epub 2014 Feb 3.
13 The PDGFR-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.Oncogene. 2017 Nov 23;36(47):6605-6616. doi: 10.1038/onc.2017.260. Epub 2017 Aug 7.
14 Genes associated with the genesis of leiomyoma of the uterus in a commonly deleted chromosomal region at 7q22.Oncol Rep. 2005 Mar;13(3):469-72.
15 The association of LAMB1 polymorphism and expression changes with the risk of coal workers' pneumoconiosis.Environ Toxicol. 2017 Sep;32(9):2182-2190. doi: 10.1002/tox.22431. Epub 2017 Apr 26.
16 Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.Neoplasia. 2005 Apr;7(4):380-9. doi: 10.1593/neo.04619.
17 Salmonella SiiE prevents an efficient humoral immune memory by interfering with IgG(+) plasma cell persistence in the bone marrow.Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7425-7430. doi: 10.1073/pnas.1818242116. Epub 2019 Mar 25.
18 Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial.Int Forum Allergy Rhinol. 2018 Jan;8(1):8-14. doi: 10.1002/alr.22041. Epub 2017 Nov 30.
19 Novel drug candidate for the treatment of several softtissue sarcoma histologic subtypes: A computational method using survivalassociated gene signatures for drug repurposing.Oncol Rep. 2019 Apr;41(4):2241-2253. doi: 10.3892/or.2019.7033. Epub 2019 Feb 26.
20 Decreased expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy.Neuromuscul Disord. 1999 Jul;9(5):326-9. doi: 10.1016/s0960-8966(99)00022-x.
21 Next Generation Proteomics for Clinical Biomarker Detection Using SWATH-MS.Methods Mol Biol. 2019;1977:3-15. doi: 10.1007/978-1-4939-9232-4_1.
22 Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy.J Natl Cancer Inst. 2020 Feb 1;112(2):179-190. doi: 10.1093/jnci/djz075.
23 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
24 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
25 Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar;25(3):771-8. doi: 10.1634/stemcells.2006-0271. Epub 2006 Nov 30.
26 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
27 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
28 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
29 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
30 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
31 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
32 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
33 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
34 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
35 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
36 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
37 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
38 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
39 Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS One. 2007 Nov 14;2(11):e1187. doi: 10.1371/journal.pone.0001187.
40 Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol. 2016 Jul;90(7):1685-94. doi: 10.1007/s00204-015-1585-7. Epub 2015 Aug 28.
41 The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models. Oncogene. 2016 Feb 18;35(7):833-45.
42 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
43 Comparative proteomics reveals concordant and discordant biochemical effects of caffeine versus epigallocatechin-3-gallate in human endothelial cells. Toxicol Appl Pharmacol. 2019 Sep 1;378:114621. doi: 10.1016/j.taap.2019.114621. Epub 2019 Jun 10.
44 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
45 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
46 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
47 Global changes in gene regulation demonstrate that unconjugated bilirubin is able to upregulate and activate select components of the endoplasmic reticulum stress response pathway. J Biochem Mol Toxicol. 2010 Mar-Apr;24(2):73-88.
48 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.